Healthcare Hedge Fund Just Invested $24.5M in Immunovant
A healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
Identify key moments to de-risk in retirement, using timing signals to reduce exposure while preserving income.
27,016 articlesA healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
Cathie Wood's bold bets launched a new era for ETFs. This piece explains how ARK helped fuel demand for active ETFs, ...
Boxer Capital quietly boosted its stake in Corvus Pharmaceuticals, a move that signals institutional faith in the bio...
Snowflake stock soaring has investors buzzing. This guide explains what's driving the rally, how to value the stock, ...
Fox stock is down after announcing a Roku deal, leaving investors weighing value vs risk. This guide breaks down the ...
OpenAI reportedly considers delaying its IPO, placing AI stocks in the spotlight. This guide breaks down the potentia...
A fresh BIT report shows the long-standing links between stocks, gold, and Bitcoin breaking down as investors chase s...
A notable stake change in Victoria’s Secret & Co. raises questions for investors. This article explains what the capi...
Two popular short-term bond ETFs—VCSH and ISTB—offer different paths to steady income. This guide breaks down cost, r...
The crypto market has questions about XRP at sub-$1.50 levels. This guide weighs the risks and potential rewards, off...
Bitcoin's renewed drop pulled Strategy, BitMine, and Robinhood shares toward monthly lows. This article breaks down w...
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...